Atlas Trials

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

Clinical trial NCT01383993 · COMPLETED

Trial details

NCT number
NCT01383993
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Aspergillosis, Aspergilloma
Start date
2011-09-01
Primary completion
2013-05-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.